{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:51:06Z","timestamp":1794369066825,"version":"4.9.0"},"publisher-location":"New York, NY","reference-count":129,"publisher":"Springer New York","isbn-type":[{"value":"9781441902979","type":"print"},{"value":"9781441902986","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-1-4419-0298-6_16","type":"book-chapter","created":{"date-parts":[[2009,12,2]],"date-time":"2009-12-02T18:39:41Z","timestamp":1259779181000},"page":"217-234","source":"Crossref","is-referenced-by-count":28,"title":["HLA-B27 Misfolding and Spondyloarthropathies"],"prefix":"10.1007","author":[{"given":"Robert A.","family":"Colbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"DeLay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlinde","family":"Layh-Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn P.","family":"Sowders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/ard.59.11.883","volume":"59","author":"M.A. Brown","year":"2000","unstructured":"Brown MA, Laval SH, Brophy S, et al. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000; 59:883\u2013886.","journal-title":"Ann Rheum Dis"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1086\/319509","volume":"68","author":"S.H. Laval","year":"2001","unstructured":"Laval SH, Timms A, Edwards S et al. Whole-genome screening in ankylosing spondylitis: Evidence of NonMHC genetic-susceptibility loci. Am J Hum Genet 2001; 68:918\u2013926.","journal-title":"Am J Hum Genet"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/art.20308","volume":"50","author":"G. Zhang","year":"2004","unstructured":"Zhang G, Luo J, Bruckel J et al. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum 2004; 50:2246\u20132254.","journal-title":"Arthritis Rheum"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05616","volume":"445","author":"R. Sladek","year":"2007","unstructured":"Sladek R, Rocheleau G, Rung J et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445:881\u2013885.","journal-title":"Nature"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/ng.2007.17","volume":"39","author":"P.R. Burton","year":"2007","unstructured":"Burton PR, Clayton DG, Cardon LR et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39:1329\u20131337.","journal-title":"Nat Genet"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.berh.2006.03.004","volume":"20","author":"J.D. Reveille","year":"2006","unstructured":"Reveille JD. Major histocompatibility genes and ankylosing spondylitis. Best Pract Res Clin Rheumatol 2006; 20:601\u2013609.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.berh.2006.03.005","volume":"20","author":"M.A. Brown","year":"2006","unstructured":"Brown MA. Non-major-histocompatibility-complex genetics of ankylosing spondylitis. Best Pract Res Clin Rheumatol 2006; 20:611\u2013621.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.berh.2006.03.001","volume":"20","author":"J.A. Smith","year":"2006","unstructured":"Smith JA, Marker-Hermann E, Colbert RA. Pathogenesis of ankylosing spondylitis: Current concepts. Best Pract Res Clin Rheumatol 2006; 20:571\u2013591.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2006.10.004","volume":"108","author":"J.A. Lopez de Castro","year":"2007","unstructured":"Lopez de Castro JA. HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol Lett 2007; 108:27\u201333.","journal-title":"Immunol Lett"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/1566524043479347","volume":"4","author":"M. Breban","year":"2004","unstructured":"Breban M, Hacquard-Bouder C, Falgarone G. Animal models of HLA-B27-associated diseases. Curr Mol Med 2004; 4:31\u201340.","journal-title":"Curr Mol Med"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/329447a0","volume":"329","author":"F. Kievits","year":"1987","unstructured":"Kievits F, Ivanyi P, Krimpenfort P et al. HLA-restricted recognition of viral antigens in HLA transgenic mice. Nature 1987; 329:447\u2013449.","journal-title":"Nature"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0198-8859(90)90033-L","volume":"28","author":"C.L. Nickerson","year":"1990","unstructured":"Nickerson CL, Luthra HS, Savarirayan S et al. Susceptibility of HLA-B27 transgenic mice to yersinia enterocolitica infection. Hum Immunol 1990; 28:382\u2013396.","journal-title":"Hum Immunol"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1084\/jem.182.4.1153","volume":"182","author":"S.D. Khare","year":"1995","unstructured":"Khare SD, Luthra HS, David CS. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking \u03b22-microglobulin: a model of human spondyloarthropathies. J Exp Med 1995; 182:1153\u20131158.","journal-title":"J Exp Med"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1172\/JCI119100","volume":"98","author":"S.D. Khare","year":"1997","unstructured":"Khare SD, Hansen J, Luthra HS et al. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27\/human \u03b22-microglobulin (\u03b22m) double transgenic mice with disrupted mouse \u03b22m. J Clin Invest 1997; 98:2746\u20132755.","journal-title":"J Clin Invest"},{"key":"16_CR15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4049\/jimmunol.160.1.101","volume":"160","author":"S.D. Khare","year":"1998","unstructured":"Khare SD, Hansen J, Luthra HS et al. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides. J Immunol 1998; 160:101\u2013106.","journal-title":"J Immunol"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/1529-0131(200010)43:10<2290::AID-ANR17>3.0.CO;2-6","volume":"43","author":"D.J. Kingsbury","year":"2000","unstructured":"Kingsbury DJ, Mear JP, Witte DP et al. Development of spontaneous arthritis in \u03b22-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression. Arthritis Rheum 2000; 43:2290\u20132296.","journal-title":"Arthritis Rheum"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/0092-8674(90)90512-D","volume":"63","author":"R.E. Hammer","year":"1990","unstructured":"Hammer RE, Maika SD, Richardson JA et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human \u03b22-m: an animal model of HLA-B27-associated human disorders. Cell 1990; 63:1099\u20131112.","journal-title":"Cell"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1600-065X.1999.tb01317.x","volume":"169","author":"J.D. Taurog","year":"1999","unstructured":"Taurog JD, Maika SD, Satumtira N et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev 1999; 169:209\u2013223.","journal-title":"Immunol Rev"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/art.21740","volume":"54","author":"T.M. Tran","year":"2006","unstructured":"Tran TM, Dorris ML, Satumtira N et al. Additional human beta(2)-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Arthritis Rheum 2006; 54:1317\u20131327.","journal-title":"Arthritis Rheum"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0198-8859(02)00364-6","volume":"63","author":"W.H. Hildebrand","year":"2002","unstructured":"Hildebrand WH, Turnquist HR, Prilliman KR et al. HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction. Hum Immunol 2002; 63:248\u2013255.","journal-title":"Hum Immunol"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/BF00163991","volume":"41","author":"Z. Yao","year":"1995","unstructured":"Yao Z, Volgger A, Scholz S et al. Sequence polymorphism in the HLA-B promoter region. Immunogenetics 1995; 41:343\u2013353.","journal-title":"Immunogenetics"},{"key":"16_CR22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-111-7-581","volume":"111","author":"D.Y. Yu","year":"1989","unstructured":"Yu DY, Choo SY, Schaack T. Molecular mimicry in HLA-B27-related arthritis. Ann Int Med 1989; 111:581\u2013591.","journal-title":"Ann Int Med"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0167-5699(90)90051-A","volume":"11","author":"R.J. Benjamin","year":"1990","unstructured":"Benjamin RJ, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990; 11:137\u2013142.","journal-title":"Immunol Today"},{"key":"16_CR24","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.4049\/jimmunol.162.9.5045","volume":"162","author":"R.L. Allen","year":"1999","unstructured":"Allen RL, O\u2019Callaghan CA, McMichael AJ et al. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol 1999; 162:5045\u20135048.","journal-title":"J Immunol"},{"key":"16_CR25","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.4049\/jimmunol.169.8.4379","volume":"169","author":"P. Malik","year":"2002","unstructured":"Malik P, Klimovitsky P, Deng LW et al. Uniquely conformed peptide-containing beta 2-microglobulin-free heavy chains of HLA-B2705 on the cell surface. J Immunol 2002; 169:4379\u20134387.","journal-title":"J Immunol"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0167-5699(00)01625-X","volume":"21","author":"J.C.W. Edwards","year":"2000","unstructured":"Edwards JCW, Bowness P, Archer JR. Jekyll and Hyde: The transformation of HLA-B27. Immunol Today 2000; 21:256\u2013260.","journal-title":"Immunol Today"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1002\/art.10605","volume":"46","author":"S. Kollnberger","year":"2002","unstructured":"Kollnberger S, Bird LA, Sunm M-Y et al. Cell surface expression and immune receptor recogntion of HLA-B27 homodimers. Arth Rheum 2002; 46:2972\u20132982.","journal-title":"Arth Rheum"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/eji.200323678","volume":"33","author":"L.A. Bird","year":"2003","unstructured":"Bird LA, Peh CA, Kollnberger S et al. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur J Immunol 2003; 33:748\u2013759.","journal-title":"Eur J Immunol"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1566524043479329","volume":"4","author":"R.L. Allen","year":"2004","unstructured":"Allen RL, Trowsdale J. Recognition of classical and heavy chain forms of HLA-B27 by leukocyte receptors. Curr Mol Med 2004; 4:59\u201365.","journal-title":"Curr Mol Med"},{"key":"16_CR30","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.4049\/jimmunol.173.3.1699","volume":"173","author":"S. Kollnberger","year":"2004","unstructured":"Kollnberger S, Bird LA, Roddis M et al. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol 2004; 173:1699\u20131710.","journal-title":"J Immunol"},{"key":"16_CR31","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.4049\/jimmunol.163.12.6665","volume":"163","author":"J.P. Mear","year":"1999","unstructured":"Mear JP, Schreiber KL, Munz C et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J Immunol 1999; 163:6665\u20136670.","journal-title":"J Immunol"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"23459","DOI":"10.1074\/jbc.M110336200","volume":"277","author":"N.S. Dangoria","year":"2002","unstructured":"Dangoria NS, DeLay ML, Kingsbury DJ et al. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J Biol Chem 2002; 277:23459\u201323468.","journal-title":"J Biol Chem"},{"key":"16_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S1357-4310(00)01699-3","volume":"6","author":"R.A. Colbert","year":"2000","unstructured":"Colbert RA. HLA-B27 misfolding: A solution to the spondyloarthropathy conundrum? Mol Med Today 2000; 6:224\u2013230.","journal-title":"Mol Med Today"},{"key":"16_CR34","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.4049\/jimmunol.175.4.2438","volume":"175","author":"M.J. Turner","year":"2005","unstructured":"Turner MJ, Sowders DP, DeLay ML et al. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J Immunol 2005; 175:2438\u20132448.","journal-title":"J Immunol"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/art.22295","volume":"56","author":"M.J. Turner","year":"2007","unstructured":"Turner MJ, Delay ML, Bai S et al. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: Implications for the pathogenesis of spondylarthritis-like disease. Arthritis Rheum 2007; 56:215\u2013223.","journal-title":"Arthritis Rheum"},{"key":"16_CR36","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/eji.1830270606","volume":"27","author":"P. Laitio","year":"1997","unstructured":"Laitio P, Virtala M, Salmi M et al. HLA-B27 modulates intracellular survival of salmonella enteritidis in human monocytic cells. Eur J Immunol 1997; 27:1331\u20131338.","journal-title":"Eur J Immunol"},{"key":"16_CR37","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1128\/IAI.65.10.4236-4242.1997","volume":"65","author":"M. Virtala","year":"1997","unstructured":"Virtala M, Kirveskari J, Granfors K. HLA-B27 modulates the survival of salmonella enteritidis in transfected L cells, possibly by impaired nitric oxide production. Infect Immun 1997; 65:4236\u20134242.","journal-title":"Infect Immun"},{"key":"16_CR38","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1002\/art.20336","volume":"50","author":"M.A. Penttinen","year":"2004","unstructured":"Penttinen MA, Heiskanen KM, Mohapatra R et al. Enhanced intracellular replication of Salmonella enteritidis in HLA-B27-expressing human monocytic cells: Dependency on glutamic acid at position 45 in the B pocket of HLA-B27. Arthritis Rheum 2004; 50:2255\u20132263.","journal-title":"Arthritis Rheum"},{"key":"16_CR39","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1002\/art.22746","volume":"56","author":"A.S. Sahlberg","year":"2007","unstructured":"Sahlberg AS, Penttinen MA, Heiskanen KM et al. Evidence that the p38 MAP kinase pathway is dysregulated in HLA-B27-expressing human monocytic cells: Correlation with HLA-B27 misfolding. Arthritis Rheum 2007; 56:2652\u20132662.","journal-title":"Arthritis Rheum"},{"key":"16_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/1566524043479275","volume":"4","author":"M.A. Penttinen","year":"2004","unstructured":"Penttinen MA, Ekman P Granfors K. Non-antigen presenting effects of HLA-B27. Curr Mol Med 2004; 4:41\u201349.","journal-title":"Curr Mol Med"},{"key":"16_CR41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.200508016","volume":"172","author":"J.P. Bridges","year":"2006","unstructured":"Bridges JP, Xu Y, Na CL et al. Adaptation and increased susceptibility to infection associated with constitutive expression of misfolded SP-C J Cell Biol 2006; 172:395\u2013407.","journal-title":"J Cell Biol"},{"key":"16_CR42","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1002\/art.10557","volume":"46","author":"M.A. Penttinen","year":"2002","unstructured":"Penttinen MA, Holmberg CI, Sistonen L et al. HLA-B27 modulates nuclear factor kB activation in human monocytic cells exposed to lipopolysaccharide. Arthritis Rheum 2002; 46:2172\u20132180.","journal-title":"Arthritis Rheum"},{"key":"16_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev.genom.7.080505.115737","volume":"7","author":"N. Gregersen","year":"2006","unstructured":"Gregersen N, Bross P, Vang S et al. Protein Misfolding and Human Disease. Annu Rev Genomics Hum Genet 2006; 7:103\u2013124.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"16_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.immuni.2007.04.003","volume":"26","author":"G.E. Hammer","year":"2007","unstructured":"Hammer GE, Kanaseki T, Shastri N. The final touches make perfect the peptide-MHC class I repertoire. Immunity 2007; 26:397\u2013406.","journal-title":"Immunity"},{"key":"16_CR45","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ni1483","volume":"8","author":"A. Kienast","year":"2007","unstructured":"Kienast A, Preuss M, Winkler M et al. Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin. Nat Immunol 2007; 8:864\u2013872.","journal-title":"Nat Immunol"},{"key":"16_CR46","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0161-5890(02)00261-4","volume":"39","author":"M. Bouvier","year":"2003","unstructured":"Bouvier M. Accessory proteins and the assembly of human class I MHC molecules: a molecular and structural perspective. Mol Immunol 2003; 39:697\u2013706.","journal-title":"Mol Immunol"},{"key":"16_CR47","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00018-003-3271-9","volume":"61","author":"T.P. Dick","year":"2004","unstructured":"Dick TP. Assembly of MHC class I peptide complexes from the perspective of disulfide bond formation. Cell Mol Life Sci 2004; 61:547\u2013556.","journal-title":"Cell Mol Life Sci"},{"key":"16_CR48","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1074-7613(00)80558-0","volume":"8","author":"C.A. Peh","year":"1998","unstructured":"Peh CA, Burrows SR, Barnden M et al. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 1998; 8:531\u2013542.","journal-title":"Immunity"},{"key":"16_CR49","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.4049\/jimmunol.166.2.1016","volume":"166","author":"A.W. Purcell","year":"2001","unstructured":"Purcell AW, Gorman JJ, Garcia-Peydro M et al. Quantitative and qualitative influences of tapasin on the class I peptide repertoire. J Immunol 2001; 166:1016\u20131027.","journal-title":"J Immunol"},{"key":"16_CR50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1074-7613(02)00263-7","volume":"16","author":"T. Dick","year":"2002","unstructured":"Dick T, Bangia N, Peaper DR et al. Disulfide bond isomerization and the assembly of MHC class I-peptide complexes. Immunity 2002; 16:87\u201398.","journal-title":"Immunity"},{"key":"16_CR51","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/89800","volume":"2","author":"T. Serwold","year":"2001","unstructured":"Serwold T, Gaw S, Shastri N. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat Immunol 2001; 2:644\u2013651.","journal-title":"Nat Immunol"},{"key":"16_CR52","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature01074","volume":"419","author":"T. Serwold","year":"2002","unstructured":"Serwold T, Gonzalez F, Kim J et al. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 2002; 419:480\u2013483.","journal-title":"Nature"},{"key":"16_CR53","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/ni1286","volume":"7","author":"G.E. Hammer","year":"2006","unstructured":"Hammer GE, Gonzalez F, Champsaur M et al. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat Immunol 2006; 7:103\u2013112.","journal-title":"Nat Immunol"},{"key":"16_CR54","doi-asserted-by":"publisher","first-page":"9202","DOI":"10.1073\/pnas.0603095103","volume":"103","author":"I.A. York","year":"2006","unstructured":"York IA, Brehm MA, Zendzian S et al. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc Natl Acad Sci USA 2006; 103:9202\u20139207.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR55","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.immuni.2006.09.012","volume":"25","author":"T. Kanaseki","year":"2006","unstructured":"Kanaseki T, Blanchard N, Hammer GE et al. ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum. Immunity 2006; 25:795\u2013806.","journal-title":"Immunity"},{"key":"16_CR56","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ni1409","volume":"8","author":"G.E. Hammer","year":"2007","unstructured":"Hammer GE, Gonzalez F, James E et al. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat Immunol 2007; 8:101\u2013108.","journal-title":"Nat Immunol"},{"key":"16_CR57","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI0213847","volume":"110","author":"X. Cui","year":"2002","unstructured":"Cui X, Hawari F, Alsaaty S et al. Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest 2002; 110:515\u2013526.","journal-title":"J Clin Invest"},{"key":"16_CR58","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.4049\/jimmunol.171.12.6814","volume":"171","author":"X. Cui","year":"2003","unstructured":"Cui X, Rouhani FN, Hawari F et al. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J Immunol 2003; 171:6814\u20136819.","journal-title":"J Immunol"},{"key":"16_CR59","doi-asserted-by":"publisher","first-page":"28677","DOI":"10.1074\/jbc.M300456200","volume":"278","author":"X. Cui","year":"2003","unstructured":"Cui X, Rouhani FN, Hawari F et al. An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. J Biol Chem 2003; 278:28677\u201328685.","journal-title":"J Biol Chem"},{"key":"16_CR60","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1146\/annurev.biochem.73.011303.074134","volume":"74","author":"M. Schroder","year":"2005","unstructured":"Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 2005; 74:739\u2013789.","journal-title":"Annu Rev Biochem"},{"key":"16_CR61","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1172\/JCI0216787","volume":"110","author":"D.H. Perlmutter","year":"2002","unstructured":"Perlmutter DH. Liver injury in alpha1-antitrypsin deficiency: An aggregated protein induces mitochondrial injury. J Clin Invest 2002; 110:1579\u20131583.","journal-title":"J Clin Invest"},{"key":"16_CR62","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ni907","volume":"4","author":"N.N. Iwakoshi","year":"2003","unstructured":"Iwakoshi NN, Lee AH, Vallabhajosyula P et al. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol 2003; 4:321\u2013329.","journal-title":"Nat Immunol"},{"key":"16_CR63","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1023\/A:1016175429877","volume":"7","author":"S. Oyadomari","year":"2002","unstructured":"Oyadomari S, Araki E, Mori M. Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis 2002; 7:335\u2013345.","journal-title":"Apoptosis"},{"key":"16_CR64","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1172\/JCI0215020","volume":"109","author":"D. Ron","year":"2002","unstructured":"Ron D. Proteotoxicity in the endoplasmic reticulum: Lessons from the Akita diabetic mouse. J Clin Invest 2002; 109:443\u2013445.","journal-title":"J Clin Invest"},{"key":"16_CR65","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0896-6273(02)01045-0","volume":"36","author":"C.M. Southwood","year":"2002","unstructured":"Southwood CM, Garbern J, Jiang W et al. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 2002; 36:585\u2013596.","journal-title":"Neuron"},{"key":"16_CR66","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/art.21103","volume":"52","author":"K. Nagaraju","year":"2005","unstructured":"Nagaraju K, Casciola-Rosen L, Lundberg I et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 2005; 52:1824\u20131835.","journal-title":"Arthritis Rheum"},{"key":"16_CR67","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/BOR.0b013e32825a6a57","volume":"19","author":"T.A. Griffin","year":"2007","unstructured":"Griffin TA, Reed AM. Pathogenesis of myositis in children. Curr Opin Rheumatol 2007; 19:487\u2013491.","journal-title":"Curr Opin Rheumatol"},{"key":"16_CR68","doi-asserted-by":"publisher","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","volume":"97","author":"K. Nagaraju","year":"2000","unstructured":"Nagaraju K, Raben N, Loeffler L et al. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci USA 2000; 97:9209\u20139214.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR69","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.1073\/pnas.90.14.6879","volume":"90","author":"R.A. Colbert","year":"1993","unstructured":"Colbert RA, Rowland-Jones SL, McMichael AJ et al. Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide. Proc Natl Acad Sci USA 1993; 90:6879\u20136883.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR70","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/ncb0805-766","volume":"7","author":"B. Meusser","year":"2005","unstructured":"Meusser B, Hirsch C, Jarosch E et al. ERAD: the long road to destruction. Nat Cell Biol 2005; 7:766\u2013772.","journal-title":"Nat Cell Biol"},{"key":"16_CR71","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.4049\/jimmunol.172.8.5110","volume":"172","author":"T.M. Tran","year":"2004","unstructured":"Tran TM, Satumtira N, Dorris ML et al. HLA-B27 in transgenic rats forms disulfide-linked heavy chain oligomers and multimers that bind to the chaperone BiP. J Immunol 2004; 172:5110\u20135119.","journal-title":"J Immunol"},{"key":"16_CR72","doi-asserted-by":"publisher","first-page":"8895","DOI":"10.1074\/jbc.M311757200","volume":"279","author":"A.N. Antoniou","year":"2004","unstructured":"Antoniou AN, Ford S, Taurog JD et al. Formation of HLA-B27 homodimers and their relationship to assembly kinetics. J Biol Chem 2004; 279:8895\u20138902.","journal-title":"J Biol Chem"},{"key":"16_CR73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1566524043479293","volume":"4","author":"R.A. Colbert","year":"2004","unstructured":"Colbert RA. The immunobiology of HLA-B27: variations on a theme. Curr Mol Med 2004; 4:21\u201330.","journal-title":"Curr Mol Med"},{"key":"16_CR74","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1002\/eji.1830231233","volume":"23","author":"M.A. Whelan","year":"1993","unstructured":"Whelan MA, Archer JR. Chemical reactivity of an HLA-B27 thiol group. Eur J Immunol 1993; 23:3278\u20133285.","journal-title":"Eur J Immunol"},{"key":"16_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0198-8859(97)00175-4","volume":"57","author":"D.D. Kostyu","year":"1997","unstructured":"Kostyu DD, Hannick LI, Traweek JL et al. HLA class I polymorphism: Structure and function and still questions. Hum Immunol 1997; 57:1\u201318.","journal-title":"Hum Immunol"},{"key":"16_CR76","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1084\/jem.178.5.1607","volume":"178","author":"M. Breban","year":"1993","unstructured":"Breban M, Hammer RE, Richardson JA et al. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med 1993; 178:1607\u20131616.","journal-title":"J Exp Med"},{"key":"16_CR77","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4049\/jimmunol.156.2.794","volume":"156","author":"M. Breban","year":"1996","unstructured":"Breban M, Fernandez-Sueiro JL, Richardson JA et al. T-cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol 1996; 156:794\u2013803.","journal-title":"J Immunol"},{"key":"16_CR78","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4049\/jimmunol.170.2.1099","volume":"170","author":"E. May","year":"2003","unstructured":"May E, Dorris ML, Satumtira N et al. CD8\u03b1\u03b2 T-cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. J Immunol 2003; 170:1099\u20131105.","journal-title":"J Immunol"},{"key":"16_CR79","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1172\/JCI118878","volume":"98","author":"H.C. Rath","year":"1996","unstructured":"Rath HC, Herfarth HH, Ikeda JS et al. Normal luminal bacteria, especially bacteroides species, mediate chronic colitis, gastritis and arthritis in HLA-B27\/human \u03b22 microglobulin transgenic rats. J Clin Invest 1996; 98:945\u2013953.","journal-title":"J Clin Invest"},{"key":"16_CR80","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1128\/IAI.67.6.2969-2974.1999","volume":"67","author":"H.C. Rath","year":"1999","unstructured":"Rath HC, Wilson KH, Sartor RB. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun 1999; 67:2969\u20132974.","journal-title":"Infect Immun"},{"key":"16_CR81","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.4049\/jimmunol.167.5.2619","volume":"167","author":"L.H. Boyle","year":"2001","unstructured":"Boyle LH, Goodall JC, Opat SS et al. The recognition of HLA-B27 by human CD4+ T-lymphocytes. J Immunol 2001; 167:2619\u20132624.","journal-title":"J Immunol"},{"key":"16_CR82","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1365-2567.2004.01857.x","volume":"112","author":"L.H. Boyle","year":"2004","unstructured":"Boyle LH, Goodall JC, Gaston JS. Major histocompatibility complex class I-restricted alloreactive CD4+ T-cells. Immunology 2004; 112:54\u201363.","journal-title":"Immunology"},{"key":"16_CR83","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4049\/jimmunol.172.1.155","volume":"172","author":"M. Roddis","year":"2004","unstructured":"Roddis M, Carter RW, Sun MY et al. Fully functional HLA B27-restricted CD4+ as well as CD8+ T-cell responses in TCR transgenic mice. J Immunol 2004; 172:155\u2013161.","journal-title":"J Immunol"},{"key":"16_CR84","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrm2199","volume":"8","author":"D. Ron","year":"2007","unstructured":"Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007; 8:519\u2013529.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"16_CR85","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.200502086","volume":"169","author":"W. Lin","year":"2005","unstructured":"Lin W, Harding HP, Ron D et al. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J Cell Biol 2005; 169:603\u2013612.","journal-title":"J Cell Biol"},{"key":"16_CR86","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/eji.200737882","volume":"38","author":"J.A. Smith","year":"2008","unstructured":"Smith JA, Turner MJ, DeLay ML, Kleck EI, Sowders DP, Colbert RA. Endoplasmic reticulum stress-induced and the unfolded protein response are linked to synergistic IFN-\u03b2 induction via X-box binding protein-1. Eur J Immunol 2008; 38:1194\u20131203.","journal-title":"Eur J Immunol"},{"key":"16_CR87","doi-asserted-by":"publisher","first-page":"7448","DOI":"10.1128\/MCB.23.21.7448-7459.2003","volume":"23","author":"A.H. Lee","year":"2003","unstructured":"Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 2003; 23:7448\u20137459.","journal-title":"Mol Cell Biol"},{"key":"16_CR88","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/35073080","volume":"2","author":"T. Taniguchi","year":"2001","unstructured":"Taniguchi T, Takaoka A. A weak signal for strong responses: Interferon-alpha\/beta revisited. Nat Rev Mol Cell Biol 2001; 2:378\u2013386.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"16_CR89","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1182\/blood.V99.9.3263","volume":"99","author":"M. Montoya","year":"2002","unstructured":"Montoya M, Schiavoni G, Mattei F et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 2002; 99:3263\u20133271.","journal-title":"Blood"},{"key":"16_CR90","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1084\/jem.20041964","volume":"201","author":"G. Gautier","year":"2005","unstructured":"Gautier G, Humbert M, Deauvieau F et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005; 201:1435\u20131446.","journal-title":"J Exp Med"},{"key":"16_CR91","doi-asserted-by":"publisher","first-page":"19794","DOI":"10.1073\/pnas.0609671104","volume":"103","author":"T.A. Seimon","year":"2006","unstructured":"Seimon TA, Obstfeld A, Moore KJ et al. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proc Natl Acad Sci USA 2006; 103:19794\u201319799.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR92","doi-asserted-by":"publisher","first-page":"21763","DOI":"10.1074\/jbc.M501759200","volume":"280","author":"Y. Li","year":"2005","unstructured":"Li Y, Schwabe RF, DeVries-Seimon T et al. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB-and map kinase-dependent inflammation in advanced atherosclerosis. J Biol Chem 2005; 280:21763\u201321772.","journal-title":"J Biol Chem"},{"key":"16_CR93","first-page":"515","volume":"54","author":"R.A. Colbert","year":"2007","unstructured":"Colbert RA, Turner MJ, DeLay ML et al. HLA-B27 misfolding activates the Il-23\/Il-17 axis via the unfolded protein response in transgenic rats: evidence for a novel mechanism of inflammation. Arth Rheum 2007; 54:S515.","journal-title":"Arth Rheum"},{"key":"16_CR94","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"T.R. Mosmann","year":"1989","unstructured":"Mosmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145\u2013173.","journal-title":"Annu Rev Immunol"},{"key":"16_CR95","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/0167-5699(88)91308-4","volume":"9","author":"K. Bottomly","year":"1988","unstructured":"Bottomly K. A functional dichotomy in CD4+ T-lymphocytes. Immunol Today 1988; 9:268\u2013274.","journal-title":"Immunol Today"},{"key":"16_CR96","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.0105-2896.2004.00214.x","volume":"202","author":"C.L. Langrish","year":"2004","unstructured":"Langrish CL, McKenzie BS, Wilson NJ et al. IL-12 and IL-23: Master regulators of innate and adaptive immunity. Immunol Rev 2004; 202:96\u2013105.","journal-title":"Immunol Rev"},{"key":"16_CR97","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"L.E. Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ effector T-cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123\u20131132.","journal-title":"Nat Immunol"},{"key":"16_CR98","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H. Park","year":"2005","unstructured":"Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T-cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6:1133\u20131141.","journal-title":"Nat Immunol"},{"key":"16_CR99","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","volume":"25","author":"C.T. Weaver","year":"2007","unstructured":"Weaver CT, Hatton RD, Mangan PR et al. IL-17 family cytokines and the expanding diversity of effector T-cell lineages. Annu Rev Immunol 2007; 25:821\u2013852.","journal-title":"Annu Rev Immunol"},{"key":"16_CR100","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"D.J. Cua","year":"2003","unstructured":"Cua DJ, Sherlock J, Chen Y et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421:744\u2013748.","journal-title":"Nature"},{"key":"16_CR101","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1172\/JCI25308","volume":"116","author":"Y. Chen","year":"2006","unstructured":"Chen Y, Langrish CL, McKenzie B et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006; 116:1317\u20131326.","journal-title":"J Clin Invest"},{"key":"16_CR102","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1172\/JCI21404","volume":"116","author":"D. Yen","year":"2006","unstructured":"Yen D, Cheung J, Scheerens H et al. IL-23 is essential for T-cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116:1310\u20131316.","journal-title":"J Clin Invest"},{"key":"16_CR103","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.immuni.2006.05.017","volume":"25","author":"H.H. Uhlig","year":"2006","unstructured":"Uhlig HH, McKenzie BS, Hue S et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 2006; 25:309\u2013318.","journal-title":"Immunity"},{"key":"16_CR104","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y. Zheng","year":"2007","unstructured":"Zheng Y, Danilenko DM, Valdez P et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445:648\u2013651.","journal-title":"Nature"},{"key":"16_CR105","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/rheumatology\/kei208","volume":"45","author":"C.H. Chen","year":"2006","unstructured":"Chen CH, Lin KC, Yu DT et al. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology (Oxford) 2006; 45:414\u2013420.","journal-title":"Rheumatology (Oxford)"},{"key":"16_CR106","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","volume":"171","author":"S. Nakae","year":"2003","unstructured":"Nakae S, Nambu A, Sudo K et al. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171:6173\u20136177.","journal-title":"J Immunol"},{"key":"16_CR107","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","volume":"21","author":"J.K. Kolls","year":"2004","unstructured":"Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21:467\u2013476.","journal-title":"Immunity"},{"key":"16_CR108","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature04754","volume":"441","author":"P.R. Mangan","year":"2006","unstructured":"Mangan PR, Harrington LE, O\u2019Quinn DB et al. Transforming growth factor-beta induces development of the T(H) 17 lineage. Nature 2006; 441:231\u2013234.","journal-title":"Nature"},{"key":"16_CR109","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/ni1539","volume":"8","author":"M.J. McGeachy","year":"2007","unstructured":"McGeachy MJ, Bak-Jensen KS, Chen Y et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T-cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007; 8:1390\u20131397.","journal-title":"Nat Immunol"},{"key":"16_CR110","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"I.I. Ivanov","year":"2006","unstructured":"Ivanov, II, McKenzie BS, Zhou L et al. The orphan nuclear receptor ROR\u03b3t directs the differentiation program of proinflammatory IL-17+T helper cells. Cell 2006; 126:1121\u20131133.","journal-title":"Cell"},{"key":"16_CR111","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1074\/jbc.M207577200","volume":"278","author":"S. Aggarwal","year":"2003","unstructured":"Aggarwal S, Ghilardi N, Xie MH et al. Interleukin-23 promotes a distinct CD4 T-cell activation state characterized by the production of interleukin-17. J Biol Chem 2003; 278:1910\u20131914.","journal-title":"J Biol Chem"},{"key":"16_CR112","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"C.L. Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T-cell population that induces autoimmune inflammation. J Exp Med 2005; 201:233\u2013240.","journal-title":"J Exp Med"},{"key":"16_CR113","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev.immunol.22.012703.104758","volume":"25","author":"R.A. Kastelein","year":"2007","unstructured":"Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007; 25:221\u2013242.","journal-title":"Annu Rev Immunol"},{"key":"16_CR114","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1084\/jem.20070663","volume":"204","author":"F. Annunziato","year":"2007","unstructured":"Annunziato F, Cosmi L, Santarlasci V et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204:1849\u20131861.","journal-title":"J Exp Med"},{"key":"16_CR115","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ni1497","volume":"8","author":"N.J. Wilson","year":"2007","unstructured":"Wilson NJ, Boniface K, Chan JR et al. Development, cytokine profile and function of human interleukin 17-producing helper T-cells. Nat Immunol 2007; 8:950\u2013957.","journal-title":"Nat Immunol"},{"key":"16_CR116","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.4049\/jimmunol.166.12.7563","volume":"166","author":"M.T. Wiekowski","year":"2001","unstructured":"Wiekowski MT, Leach MW, Evans EW et al. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility and premature death. J Immunol 2001; 166:7563\u20137570.","journal-title":"J Immunol"},{"key":"16_CR117","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","volume":"17","author":"C.A. Biron","year":"1999","unstructured":"Biron CA, Nguyen KB, Pien GC et al. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol 1999; 17:189\u2013220.","journal-title":"Annu Rev Immunol"},{"key":"16_CR118","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1002\/art.22807","volume":"56","author":"J.D. Taurog","year":"2007","unstructured":"Taurog JD. The mystery of HLA-B27: if it isn\u2019t one thing, it\u2019s antoher. Arthritis Rheum 2007; 56:2478\u20132481.","journal-title":"Arthritis Rheum"},{"key":"16_CR119","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/ard.59.8.654a","volume":"59","author":"I. Olivieri","year":"2000","unstructured":"Olivieri I, Padula A, Ciancio G et al. The HLA-B*2709 subtype in a patient with undifferentiated spondarthritis. Ann Rheum Dis 2000; 59:654\u2013655.","journal-title":"Ann Rheum Dis"},{"key":"16_CR120","first-page":"265","volume":"43","author":"I. Olivieri","year":"2000","unstructured":"Olivieri I, Ciancio G, Padula A et al. The B*2709 subtype does not give absolute protection against spondyloarthropathy. Arthritis Rheum 2000; 43:S265.","journal-title":"Arthritis Rheum"},{"key":"16_CR121","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1002\/art.22821","volume":"56","author":"I. Olivieri","year":"2007","unstructured":"Olivieri I, D\u2019Angelo S, Scarano E et al. The HLA-B*2709 subtype in a woman with early ankylosing spondylitis. Arthritis Rheum 2007; 56:2805\u20132807.","journal-title":"Arthritis Rheum"},{"key":"16_CR122","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1002\/art.22819","volume":"56","author":"A. Cauli","year":"2007","unstructured":"Cauli A, Vacca A, Mameli A et al. A Sardinian patient with ankylosing spondylitis and HLA-B*2709 co-occurring with HLA-B*1403. Arthritis Rheum 2007; 56:2807\u20132809.","journal-title":"Arthritis Rheum"},{"key":"16_CR123","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/art.10948","volume":"48","author":"M.T. Fiorillo","year":"2003","unstructured":"Fiorillo MT, Cauli A, Carcassi C et al. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for pathogenesis. Arth Rheum 2003; 48:1385\u20131389.","journal-title":"Arth Rheum"},{"key":"16_CR124","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/ard.61.3.193","volume":"61","author":"J.D. Taurog","year":"2002","unstructured":"Taurog JD. HLA-DR4 and the spondyloarthropathies. Ann Rheum Dis 2002; 61:193\u2013194.","journal-title":"Ann Rheum Dis"},{"key":"16_CR125","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1399-0039.1995.tb02436.x","volume":"45","author":"C. Lopez-Larrea","year":"1995","unstructured":"Lopez-Larrea C, Sujirachato K, Mehra NK et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis: evidence for new associations. Tissue Antigens 1995; 45:169\u2013176.","journal-title":"Tissue Antigens"},{"key":"16_CR126","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1399-0039.1997.tb02724.x","volume":"49","author":"S. Gonzalez-Roces","year":"1997","unstructured":"Gonzalez-Roces S, Alvarez MV, Gonzalez S et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997; 49:116\u2013123.","journal-title":"Tissue Antigens"},{"key":"16_CR127","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1445-5994.2007.01450.x","volume":"37","author":"T.Y. Hou","year":"2007","unstructured":"Hou TY, Chen HC, Chen CH et al. Usefulness of human leucocyte antigen-B27 subtypes in predicting ankylosing spondylitis: Taiwan experience. Intern Med J 2007; 37:749\u2013752.","journal-title":"Intern Med J"},{"key":"16_CR128","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.1135245","volume":"314","author":"R.H. Duerr","year":"2006","unstructured":"Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study indentifies IL23R as an inflammatory bowel disease gene. Science 2006; 314:1461\u20131463.","journal-title":"Science"},{"key":"16_CR129","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/511051","volume":"80","author":"M. Cargill","year":"2007","unstructured":"Cargill M, Schrodi SJ, Chang M et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80:273\u2013290.","journal-title":"Am J Hum Genet"}],"container-title":["Advances in Experimental Medicine and Biology","Molecular Mechanisms of Spondyloarthropathies"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-0298-6_16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T19:41:30Z","timestamp":1710704490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4419-0298-6_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9781441902979","9781441902986"],"references-count":129,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-0298-6_16","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4419-0298-6","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}